mutLBSgeneDB

mutLBSgeneDB
mutated Ligand Binding Site gene DataBase

Home

Download

 Statistics

Help

About Us

Bioinformatics and Systems Medicine Laboratory Bioinformatics and Systems Medicine Laboratory

Gene Summary

Ligand Binding Site Mutation Information

Protein Structure Related Information

Gene Expression and Gene-Gene Network

Phenotype Information

Pharmacological Information

Conservation Information for LBS

Gene summary for ING4
Gene summary
Basic gene Info.Gene symbolING4
Gene nameinhibitor of growth family, member 4
Synonymsmy036|p29ING4
CytomapUCSC genome browser: 12p13.31
Type of geneprotein-coding
RefGenesNM_001127582.1,
NM_001127583.1,NM_001127584.1,NM_001127585.1,NM_001127586.1,
NM_016162.3,NM_198287.1,
Descriptionbrain my036 proteincandidate tumor suppressor p33 ING1 homologinhibitor of growth protein 4
Modification date20141207
dbXrefs MIM : 608524
HGNC : HGNC
Ensembl : ENSG00000111653
HPRD : 09774
Vega : OTTHUMG00000141274
ProteinUniProt: Q9UNL4
go to UniProt's Cross Reference DB Table
ExpressionCleanEX: HS_ING4
BioGPS: 51147
PathwayNCI Pathway Interaction Database: ING4
KEGG: ING4
REACTOME: ING4
Pathway Commons: ING4
ContextiHOP: ING4
ligand binding site mutation search in PubMed: ING4
UCL Cancer Institute: ING4
Assigned class in mutLBSgeneDBC: This gene just belongs to mutLBSgenes.

Gene ontology having evidence of Inferred from Direct Assay (IDA) from Entrez
GO IDGO TermPubMed ID
GO:0006260DNA replication16387653
GO:0006473protein acetylation12750254
GO:0006915apoptotic process15251430
GO:0006978DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator16387653
GO:0007050cell cycle arrest15251430
GO:0008285negative regulation of cell proliferation12750254
GO:0043065positive regulation of apoptotic process16387653
GO:0043966histone H3 acetylation16387653
GO:0043981histone H4-K5 acetylation16387653
GO:0043982histone H4-K8 acetylation16387653
GO:0043983histone H4-K12 acetylation16387653
GO:0043984histone H4-K16 acetylation16387653
GO:0045892negative regulation of transcription, DNA-templated15029197
GO:0045926negative regulation of growth12750254


Top
Ligand binding site mutations for ING4
Lollipop-style diagram of mutations at LBS in amino-acid sequence.
We represented ligand binding site mutations only. (You can see big image via clicking.)
 
: non-synonymous mutation on LBS, Circle size denotes number of samples.

Cancer type specific mutLBS sorted by frequency
LBSAAchange of nsSNVCancer type# samples
W221W221RCOAD1
G235G235RGBM1
Y198T197NSKCM1
cf) Cancer type abbreviation. BLCA: Bladder urothelial carcinoma, BRCA: Breast invasive carcinoma, CESC: Cervical squamous cell carcinoma and endocervical adenocarcinoma, COAD: Colon adenocarcinoma, GBM: Glioblastoma multiforme, LGG: Brain lower grade glioma, HNSC: Head and neck squamous cell carcinoma, KICH: Kidney chromophobe, KIRC: Kidney renal clear cell carcinoma, KIRP: Kidney renal papillary cell carcinoma, LAML: Acute myeloid leukemia, LUAD: Lung adenocarcinoma, LUSC: Lung squamous cell carcinoma, OV: Ovarian serous cystadenocarcinoma, PAAD: Pancreatic adenocarcinoma, PRAD: Prostate adenocarcinoma, SKCM: Skin cutaneous melanoma, STAD: Stomach adenocarcinoma, THCA: Thyroid carcinoma, UCEC: Uterine corpus endometrial carcinoma.


Top
Protein structure related information for ING4
Relative protein structure stability change (ΔΔE) using Mupro 1.1
Mupro score denotes assessment of the effect of mutations on thermodynamic stability.
  (ΔΔE<0: mutation decreases stability, ΔΔE>0: mutation increases stability)
: nsSNV at non-LBS: nsSNV at LBS

nsSNVs sorted by the relative stability change of protein structure by each mutation
Blue: mutations of positive stability change. and red : the most recurrent mutation for this gene.
LBSAAchange of nsSNVRelative stability change
Y198T197N-1.2474801
W221W221R-1.155592
G235G235R-0.72772323
(MuPro1.1: Jianlin Cheng et al., Prediction of Protein Stability Changes for Single-Site Mutations Using Support Vector Machines, PROTEINS: Structure, Function, and Bioinformatics. 2006, 62:1125-1132)

Structure image for ING4 from PDB

Top
Differential gene expression and gene-gene network for ING4
Differential gene expression between mutated and non-mutated LBS samples in all 16 major cancer types

Differential co-expressed gene network based on protein-protein interaction data (CePIN)
* Left PPI network was created from samples with mutations in the LBS of ING4 and the right PPI network was created from samples without mutations in the LBS of ING4. Only genes with p-value < 0.05 are shown.
Red circle: input gene. Orange circle: LBSgene. Blue circle: other gene.


Top

Top
Phenotype information for ING4
Gene level disease information (DisGeNet)
Disease IDDisease name# PubMedAssociation type

Mutation level pathogenic information (ClinVar annotation)
Allele IDAA changeClinical significanceOriginPhenotype IDs

Top
Pharmacological information for ING4
Gene expression profile of anticancer drug treated cell-lines (CCLE)
Heatmap showing the correlation between gene expression and drug response across all the cell-lines. We chose the top 20 among 138 drugs.We used Pearson's correlation coefficient.
Drug information targeting mutLBSgene (Approved drugs only)
Drug statusDrugBank IDNameTypeDrug structure

Gene-centered ligand-gene interaction network

Ligands binding to mutated ligand binding site of ING4 go to BioLip
Ligand IDLigand short nameLigand long namePDB IDPDB namemutLBS
IIIPeptide ligand (ALA,ARG,THR,LYS,GLN,THR,ALA,ARG)2pnxAY198 W221 G235
IIIPeptide ligand (ALA,ARG,THR,LYS,GLN,THR,ALA,ARG,LYS,SER,THR)2pnxCY198 W221 G235
IIIPeptide ligand (ALA,ARG,THR,LYS,GLN,THR)2vnfAY198 W221 G235
IIIPeptide ligand (ALA,ARG,THR,LYS,GLN,THR,ALA,ARG,LYS,SER)2vnfCY198 W221 G235


Top
Conservation information for LBS of ING4
Multiple alignments for Q9UNL4 in multiple species
LBSAA sequence# speciesSpecies
C199NEPTYCLCHQV4Homo sapiens, Gallus gallus, Bos taurus, Mus musculus
C201PTYCLCHQVSY4Homo sapiens, Gallus gallus, Bos taurus, Mus musculus
C212GEMIGCDNPDC4Homo sapiens, Gallus gallus, Bos taurus, Mus musculus
C217CDNPDCSIEWF3Homo sapiens, Gallus gallus, Mus musculus
C217CDNPDCSIERF1Bos taurus
C226WFHFACVGLTT3Homo sapiens, Gallus gallus, Mus musculus
C226RFHFACVGLTT1Bos taurus
C239RGKWFCPRCSQ4Homo sapiens, Gallus gallus, Bos taurus, Mus musculus
C242WFCPRCSQERK4Homo sapiens, Gallus gallus, Bos taurus, Mus musculus
D213EMIGCDNPDCS4Homo sapiens, Gallus gallus, Bos taurus, Mus musculus
E195PVDPNEPTYCL4Homo sapiens, Gallus gallus, Bos taurus, Mus musculus
E208QVSYGEMIGCD4Homo sapiens, Gallus gallus, Bos taurus, Mus musculus
E220PDCSIEWFHFA3Homo sapiens, Gallus gallus, Mus musculus
E220PDCSIERFHFA1Bos taurus
F222CSIEWFHFACV3Homo sapiens, Gallus gallus, Mus musculus
F222CSIERFHFACV1Bos taurus
F224IEWFHFACVGL3Homo sapiens, Gallus gallus, Mus musculus
F224IERFHFACVGL1Bos taurus
G207HQVSYGEMIGC4Homo sapiens, Gallus gallus, Bos taurus, Mus musculus
G211YGEMIGCDNPD4Homo sapiens, Gallus gallus, Bos taurus, Mus musculus
G235TTKPRGKWFCP4Homo sapiens, Gallus gallus, Bos taurus, Mus musculus
H223SIEWFHFACVG3Homo sapiens, Gallus gallus, Mus musculus
H223SIERFHFACVG1Bos taurus
I210SYGEMIGCDNP4Homo sapiens, Gallus gallus, Bos taurus, Mus musculus
K232VGLTTKPRGKW4Homo sapiens, Gallus gallus, Bos taurus, Mus musculus
M209VSYGEMIGCDN4Homo sapiens, Gallus gallus, Bos taurus, Mus musculus
P233GLTTKPRGKWF4Homo sapiens, Gallus gallus, Bos taurus, Mus musculus
Q203YCLCHQVSYGE4Homo sapiens, Gallus gallus, Bos taurus, Mus musculus
S205LCHQVSYGEMI4Homo sapiens, Gallus gallus, Bos taurus, Mus musculus
W221DCSIEWFHFAC3Homo sapiens, Gallus gallus, Mus musculus
W221DCSIERFHFAC1Bos taurus
Y198PNEPTYCLCHQ4Homo sapiens, Gallus gallus, Bos taurus, Mus musculus
Y206CHQVSYGEMIG4Homo sapiens, Gallus gallus, Bos taurus, Mus musculus


Copyright © 2016-Present - The University of Texas Health Science Center at Houston
Site Policies | State of Texas